§ 13F · FUND PROFILE
Foresite Capital Management IV, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $123.8T (13F)Positions · 6Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$229.7T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | PHVS | Pharvaris N.V. | 4.78M | $132.6T | 57.7% | NEW |
| 2 | CYTK | CYTOKINETICS INC | 458K | $29.1T | 12.7% | NEW |
| 3 | LYEL | Lyell Immunopharma, Inc. | 800K | $24.6T | 10.7% | NEW |
| 4 | MAZE | Maze Therapeutics, Inc. | 523K | $21.7T | 9.4% | NEW |
| 5 | RLAY | Relay Therapeutics, Inc. | 1.00M | $8.5T | 3.7% | NEW |
| 6 | XENE | Xenon Pharmaceuticals Inc. | 160K | $7.2T | 3.1% | NEW |
| 7 | ALEC | Alector, Inc. | 3.89M | $6.1T | 2.6% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FORESITE SIGNAL
AC read
Foresite Capital Management IV, LLC is a Other fund managing $123796.4 trillion in assets. The fund runs a focused portfolio of just 6 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed